SG11202103373QA - LEUCINE-RICH α2 GLYCOPROTEIN COMPOSITION - Google Patents
LEUCINE-RICH α2 GLYCOPROTEIN COMPOSITIONInfo
- Publication number
- SG11202103373QA SG11202103373QA SG11202103373QA SG11202103373QA SG11202103373QA SG 11202103373Q A SG11202103373Q A SG 11202103373QA SG 11202103373Q A SG11202103373Q A SG 11202103373QA SG 11202103373Q A SG11202103373Q A SG 11202103373QA SG 11202103373Q A SG11202103373Q A SG 11202103373QA
- Authority
- SG
- Singapore
- Prior art keywords
- leucine
- rich
- glycoprotein composition
- glycoprotein
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018190904 | 2018-10-09 | ||
| PCT/JP2019/039565 WO2020075692A1 (en) | 2018-10-09 | 2019-10-08 | LEUCINE RICH α2 GLYCOPROTEIN COMPOSITION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202103373QA true SG11202103373QA (en) | 2021-05-28 |
Family
ID=70165198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202103373QA SG11202103373QA (en) | 2018-10-09 | 2019-10-08 | LEUCINE-RICH α2 GLYCOPROTEIN COMPOSITION |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220127314A1 (en) |
| EP (1) | EP3865503A4 (en) |
| JP (1) | JP7421712B2 (en) |
| KR (1) | KR20210073547A (en) |
| CN (1) | CN112789288A (en) |
| SG (1) | SG11202103373QA (en) |
| WO (1) | WO2020075692A1 (en) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2718325C2 (en) * | 1977-04-25 | 1986-09-25 | Behringwerke Ag, 3550 Marburg | High Leucine 3.1-S-αγ2γ-glycoprotein and its use |
| US7416850B2 (en) * | 2006-01-25 | 2008-08-26 | Jemmerson Ronald R | Cytochrome c and leucine-rich alpha-2-glycoprotein-1 assays, methods and antibodies |
| JP5422108B2 (en) * | 2007-10-16 | 2014-02-19 | 栄研化学株式会社 | Heme protein stabilization method and storage solution |
| JP5246709B2 (en) | 2009-06-09 | 2013-07-24 | 独立行政法人医薬基盤研究所 | Biomarker for testing autoimmune disease and testing method |
| WO2011015602A2 (en) * | 2009-08-04 | 2011-02-10 | Biosystems International Sas | Lung cancer biomarkers |
| JP5717021B2 (en) | 2009-12-03 | 2015-05-13 | 独立行政法人医薬基盤研究所 | Angiogenesis-inducing molecule |
| JP5914326B2 (en) | 2010-03-31 | 2016-05-11 | 積水メディカル株式会社 | Measuring method using immunochromatography, test strip for immunochromatography and measuring reagent kit for immunochromatography |
| CN102243240B (en) * | 2010-05-11 | 2014-08-27 | 中国科学院上海生命科学研究院 | Non-small cell lung cancer molecular marker and its application |
| JP6013717B2 (en) | 2010-09-30 | 2016-10-25 | 積水メディカル株式会社 | Protein solution which can be stored in liquid and method for storing protein solution in liquid |
| JP6675605B2 (en) | 2014-10-10 | 2020-04-01 | 国立大学法人高知大学 | Prevention and treatment of diseases related to regulation of cell migration and evaluation of disease activity and prognosis of pulmonary interstitial diseases |
| KR20160045547A (en) * | 2014-10-17 | 2016-04-27 | 에스케이텔레콤 주식회사 | Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using the same |
| KR101853118B1 (en) * | 2016-09-02 | 2018-04-30 | 주식회사 바이오인프라생명과학 | Complex biomarker group for detecting lung cancer in a subject, lung cancer diagnostic kit using the same, method for detecting lung cancer using information on complex biomarker and computing system executing the method |
| CN110412294B9 (en) * | 2019-08-07 | 2023-05-26 | 深圳市新产业生物医学工程股份有限公司 | Protein stabilizing solution, protein calibrator, kit and method for detecting stability of protein calibrator |
-
2019
- 2019-10-08 JP JP2020551154A patent/JP7421712B2/en active Active
- 2019-10-08 US US17/282,325 patent/US20220127314A1/en active Pending
- 2019-10-08 CN CN201980065023.1A patent/CN112789288A/en active Pending
- 2019-10-08 EP EP19871764.7A patent/EP3865503A4/en active Pending
- 2019-10-08 WO PCT/JP2019/039565 patent/WO2020075692A1/en unknown
- 2019-10-08 SG SG11202103373QA patent/SG11202103373QA/en unknown
- 2019-10-08 KR KR1020217013499A patent/KR20210073547A/en active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| EP3865503A1 (en) | 2021-08-18 |
| JP7421712B2 (en) | 2024-01-25 |
| US20220127314A1 (en) | 2022-04-28 |
| EP3865503A4 (en) | 2022-07-13 |
| KR20210073547A (en) | 2021-06-18 |
| JPWO2020075692A1 (en) | 2021-09-24 |
| CN112789288A (en) | 2021-05-11 |
| WO2020075692A1 (en) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201908604B (en) | Whitening composition | |
| EP3632941C0 (en) | Resin composition | |
| GB201911800D0 (en) | Antiflouling Composition | |
| SG11202012734YA (en) | Composition | |
| GB201811100D0 (en) | Composition | |
| GB2606975B (en) | Composition | |
| GB201820878D0 (en) | Composition | |
| GB201804434D0 (en) | Composition | |
| GB2583851B (en) | Composition | |
| GB201909924D0 (en) | Composition | |
| SG11202011204PA (en) | Composition | |
| GB201901161D0 (en) | Composition | |
| GB201818827D0 (en) | Composition | |
| PL3571933T3 (en) | Composition | |
| SG11202103373QA (en) | LEUCINE-RICH α2 GLYCOPROTEIN COMPOSITION | |
| SG11202102216QA (en) | Polysiloxane composition | |
| SG11202011908YA (en) | Delamanid-containing composition | |
| GB201819861D0 (en) | Composition | |
| GB201815032D0 (en) | Composition | |
| GB201809123D0 (en) | Composition | |
| GB201801596D0 (en) | Composition | |
| SG11202105131TA (en) | Polyamide composition | |
| GB201913398D0 (en) | Composition | |
| GB201820082D0 (en) | Composition | |
| GB201818567D0 (en) | Composition |